Pfizer's pursuit of Britain's second-largest drugmaker has sparked a political storm in Britain, with the government initially accused of acting as cheerleader for what would be the country's largest foreign takeover.
With the opposition Labour party leading the complaints, Cameron is now seeking to protect jobs and scientific research while also sending the message that Britain remains open to investment from foreign companies.
Also Read
Pfizer has already given a five-year commitment to complete AstraZeneca's new research centre in Cambridge, retain a factory in the northwestern English town of Macclesfield and put a fifth of its research staff in Britain if the deal goes ahead.
But the US firm has also said it could adjust those promises if circumstances change "significantly", prompting demands for more watertight pledges.
"Don't underestimate the power of some of the things they have already said, about making sure, for instance, that 20 per cent of their R&D jobs will be here in the UK," Cameron said. "Now I want more."
Pfizer on Saturday sought to fight back against the mounting criticism, saying Britain's expertise in research was a key reason for the deal. Chief Executive Ian Read will take that message with him when he appears before two panels of British lawmakers this week to face questions over the takeover.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)